


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.58%
-7.38%
-3.40%
+0.49%
RJF
Raymond James Financial
$153.93

Login to see Raymond James Financial (RJF) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
RJF Price Performance
$151.02 (+1.93%)
$143.81 (+7.04%)
$168.31 (-8.54%)
$153.37 (+0.37%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Has a Strong balance sheet
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Expands stock buyback program
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Outperform the market
Trading below its fair value
RJF Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RJF Street Sentiment is extremely bullish and have positive views on the near-term outlook
RJF has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Apr 30, 2026
Upgrade
Buy
BofA
Apr 30, 2026
Upgrade
Buy
Raymond James
Apr 30, 2026
Upgrade
spend
Raymond James
Mar 30, 2026
Downgrade
Outperform
Raymond James
Mar 30, 2026
Reiterate
Buy
Raymond James
PIPR
Piper Sandler Companies
79.55
+2.09%
JEF
Jefferies Financial Group
61.62
+3.28%
SNEX
StoneX Group
131.67
+1.48%
BLK
BlackRock
1031.83
+1.56%
WT
WisdomTree
17.70
+2.46%
What is RJF current stock price?
What is RJF current Stock IQ?
What is RJF RSI signal right now?
What is RJF analyst price target and upside potential?
What do analysts say about RJF stock?
What is RJF momentum trend right now?
What are RJF stock strengths?
What is RJF Risk Level?
Should I buy RJF stock right now?
Is RJF a Strong Buy right now?
What is RJF market cap and volume?
What factors influence RJF's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
RJF
Raymond James Financial
Current Price
$153.93
PIPR
Piper Sandler Companies
79.55
+2.09%
JEF
Jefferies Financial Group
61.62
+3.28%
SNEX
StoneX Group
131.67
+1.48%
BLK
BlackRock
1031.83
+1.56%
WT
WisdomTree
17.70
+2.46%

RJF Price Performance
$151.02 (+1.93%)
$143.81 (+7.04%)
$168.31 (-8.54%)
$153.37 (+0.37%)
RJF Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Has a Strong balance sheet
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Expands stock buyback program
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Outperform the market
Trading below its fair value
RJF Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RJF Street Sentiment is extremely bullish and have positive views on the near-term outlook
RJF has Low risk level

Overall Wall Street Rating
RJF Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
RJF Trading Signals
RJF received an analyst buy rating. 5 Hot Biotech Stocks Under $5 to Buy. In this article we will list the 5 Hot Biotech Stocks Under $5 to Buy. Please visit 10 Hot Biotech Stocks Under ...
RJF received an analyst buy rating. Analysts Grow More Confident In Equillium’.s (EQ) Lead Asset EQ504. Equillium Inc. (NASDAQ: EQ ) with a year-to-date gain of 89.68% and upside po...
RJF received an analyst buy rating. 10 Hot Biotech Stocks Under $5 to Buy. In this piece we discuss the 10 Hot Biotech Stocks Under $5 to Buy . Biotech is having one of its strongest yea...
RJF received an analyst upgrade. What Do Analysts Say About InflaRx N.V. (IFRX)?. While InflaRx N.V. (NASDAQ: IFRX ) has gained 82.18% year-to-date analysts continue to see 385.90% up...
RJF is trading 56.23% below analyst target price of $235.00, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.